Mark W Johnson. Show Affiliations »
Abstract
Mesh: See more » Eye Diseases/diagnosisEye Diseases/drug therapyEye Diseases/surgeryEye Diseases/therapyFibrinolysin/therapeutic useFluorocarbons/administration & dosageHumansPeptide Fragments/therapeutic usePressureRetinal Diseases/diagnosisRetinal Diseases/drug therapyRetinal Diseases/surgeryRetinal Diseases/therapyTomography, Optical CoherenceTractionVitrectomyVitreous Body
Substances: See more » FluorocarbonsPeptide FragmentsmicroplasminperflutrenFibrinolysin
Year: 2013 PMID: 23312439 DOI: 10.1016/j.ajo.2012.10.016
Source DB: PubMed Journal: Am J Ophthalmol ISSN: 0002-9394 Impact factor: 5.258